BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Reata Pharmaceuticals, Inc. 

1950 Stemmons Freeway, Suite 5001

Dallas  Texas  75207  U.S.A.
Phone: 214-800-8700 Fax: 214-722-0867


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Abbott Laboratories (ABT), Reata Pharmaceuticals, Inc. Kidney Disease Drug Trial Stopped 10/18/2012 9:42:10 AM    More...
Reata Pharmaceuticals, Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference 1/6/2012 11:13:10 AM    More...
Reata Pharmaceuticals, Inc. Release: New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 11/29/2011 11:52:45 AM    More...
Reata Pharmaceuticals, Inc. Adds Executives to Management Team and Board of Directors 10/17/2011 10:46:12 AM    More...
Reata Pharmaceuticals, Inc. and Abbott Laboratories (ABT) Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 6/16/2011 9:08:28 AM    More...
Reata Pharmaceuticals, Inc. and Abbott Laboratories (ABT) Announce Positive Phase 2b Study Results for Bardoxolone Methyl 11/22/2010 7:51:39 AM    More...
Reata Pharmaceuticals, Inc. to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease 11/11/2010 11:27:26 AM    More...
Reata Pharmaceuticals, Inc. Adding Jobs, Stays in Dallas Because of Abbott Laboratories (ABT) Deal 10/4/2010 8:25:58 AM    More...
Abbott Laboratories (ABT) and Reata Pharmaceuticals, Inc. Announce Agreement Worth at Least $450 Million to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. 9/23/2010 6:42:11 AM    More...
Reata Pharmaceuticals, Inc. Completes $78 Million Equity Financing for Second Pivotal Trial of Bardoxolone Methylr 7/12/2010 7:14:53 AM    More...
1234

//-->